Clinical practice guidelines for the African American women with HIV and secondary dyslipidemia

2^nd International Conference on Nursing & Healthcare

November 17-19, 2014 DoubleTree by Hilton Hotel Chicago-North Shore Conference Center, USA

Rose Knapp

Accepted Abstracts: J Nurs Care

Abstract :

Despite initiatives by the American Heart Association and the National Institute of Health, cardiovascular disease remains the number one killer of African-American women in the United States. This alarming health disparity in diagnosis, treatment, and research specific to women particularly African-American women must be reduced to improve their overall health and longevity. African-American women are also at a greater risk for HIV. The antiretroviral therapy which has prolonged the life of patients with HIV unfortunately predisposes them to secondary dyslipidemia, a significant reversible risk factor for cardiovascular disease. African-American women with HIV are greatly predisposed to cardiovascular disease as a result of their ethnicity, gender, lifestyle, and antiretroviral therapy. Clinical practice standards including managing complex drug-drug interactions and life-style modifications must be developed for this unique patient population. Along with clinical practice standards, it is imperative that providers take a leadership role to break the barriers to quality healthcare, implement patient education programs and foster patient empowerment to prevent the continued high mortality rates in African-American women with HIV as a result of cardiovascular disease.